infliximab monoclonal antibody fragment drug. targets tnf-alpha, indications for use include crohn's disease, ulcerative

ada alpha ankylosing antibody antidrug arthritis autoimmune biological biosimilar biotech biotechnology chimeric colitis crohn disease drug factor immune immunoglobulin immunology immunosuppressant infliximab infusion injection inn mab monoclonal necrosis nomenclature peptide protein psoriasis rheumatoid spondylitis tnf tnfa tumor ulcerative